Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane vs Megestrol Acetate Follow-up in Metastatic Breast Cancer
NCT01237327Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2001
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by Pfizer. Started Nov 2001; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01237327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237327.